Verification of mechanism that CSC markers are implicated in poor prognosis for pancreatic ductal adenocarcinoma

被引：0
|
作者：
Arima, K. [1 ]
Ishimoto, T. [1 ]
Ohmuraya, M. [2 ]
Okabe, H. [1 ]
Kitano, Y. [1 ]
Yamamura, K. [1 ]
Kaida, T. [1 ]
Nakagawa, S. [1 ]
Imai, K. [1 ]
Hashimoto, D. [1 ]
Chikamoto, A. [1 ]
Yamashita, Y-I [1 ]
Baba, H. [1 ]
机构：
[1] Kumamoto Univ, Dept Gastroenterol, Kumamoto, Japan
[2] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Complex glandular pattern is an aggressive morphology that predicts poor prognosis of pancreatic ductal adenocarcinoma
    Kouchi, Yusuke
    Takano, Shigetsugu
    Harada-Kagitani, Sakurako
    Shinomiya, Yoshiki
    Yogi, Norikazu
    Sakamoto, Toshiya
    Mishima, Takashi
    Fugo, Kazunori
    Kambe, Michiyo
    Nagai, Yuichiro
    Nakatani, Yukio
    Ikeda, Jun-ichiro
    Ohtsuka, Masayuki
    Kishimoto, Takashi
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 64
  • [42] High expression of WISP-1 correlates with poor prognosis in pancreatic ductal adenocarcinoma
    Yang, Jian-Yu
    Yang, Min-Wei
    Huo, Yan-Miao
    Liu, Wei
    Liu, De-Jun
    Li, Jiao
    Zhang, Jun-Feng
    Hua, Rong
    Sun, Yong-Wei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (09): : 1621 - 1628
  • [43] N-WASP in Pancreatic Ductal Adenocarcinoma: Associations with Perineural Invasion and Poor Prognosis
    Guo, Jun-Chao
    Li, Jian
    Zhao, Yu-Pei
    Zhou, Li
    Cui, Quan-Cai
    Zhou, Wei-Xun
    Zhang, Tai-Ping
    You, Lei
    Shu, Hong
    WORLD JOURNAL OF SURGERY, 2014, 38 (08) : 2126 - 2131
  • [44] Major Molecular Markers in Pancreatic Ductal Adenocarcinoma and Their Roles in Screening, Diagnosis, Prognosis, and Treatment
    Singh, Puneet
    Srinivasan, Radhika
    Wig, Jai Dev
    PANCREAS, 2011, 40 (05) : 644 - 652
  • [45] Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
    MacCurtain, Benjamin M.
    Quirke, Ned P.
    Thorpe, Stephen D.
    Gallagher, Tom K.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [46] Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma
    Robin, Fabien
    Angenard, Gaelle
    Cano, Luis
    Courtin-Tanguy, Laetitia
    Gaignard, Elodie
    Khene, Zine-Eddine
    Bergeat, Damien
    Clement, Bruno
    Boudjema, Karim
    Coulouarn, Cedric
    Sulpice, Laurent
    BRITISH JOURNAL OF CANCER, 2020, 123 (01) : 72 - 80
  • [47] Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
    Morimachi, Masashi
    Hirabayashi, Kenichi
    Takanashi, Yumi
    Kawanishi, Aya
    Saika, Tsubasa
    Ueyama, Yumiko
    Nakagohri, Toshio
    Nakamura, Naoya
    Suzuki, Hidekazu
    Kagawa, Tatehiro
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (11) : 741 - 745
  • [48] High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma
    Wang, Lei
    Gu, Feng
    Liu, Chao-Ying
    Wang, Run-Jie
    Li, Jiang
    Xu, Jun-Ying
    TUMOR BIOLOGY, 2013, 34 (02) : 853 - 858
  • [49] Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma
    Huang, Xinyang
    Zhao, Liangchao
    Jin, Yixun
    Wang, Zhuoxin
    Li, Tong
    Xu, Hui
    Wang, Qi
    Wang, Lifu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma
    Li, Jian
    Hu, Guohuang
    Kong, Fujiao
    Wu, Kemin
    Song, Kun
    He, Jianfeng
    Sun, Weijia
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (04) : 1013 - 1020
12345